Gilead Sciences, Inc.

Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: $0

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
ASMB	Assembly Biosciences, INC.	$0	$0	$0	5M	May 26
XLO	Xilio Therapeutics, Inc.	$0	$0	$0	—	Feb 13

ASMB

Assembly Biosciences, INC.

Bought

Sold

Held

XLO

Xilio Therapeutics, Inc.

Bought

Sold

Held

—

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

1 of 5 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 36 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Company	Past deadline	Largest line	Source
Aug 8, 2025	Oct 2, 2025	ASMBAssembly Biosciences, INC.	36days · about 2 months	—	Filing ↗

ASMB

Assembly Biosciences, INC.

36days · about 2 months

Traded Aug 8, 2025 · filed Oct 2, 2025Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.

Trade history

The 11 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
May 26	ASMB	Assembly Biosciences, INC.	AGRANT	471,698	$26.50	$12.5M	+10.5%	Open the original filing on SEC.gov
Feb 13	XLO	Xilio Therapeutics, Inc.	PDBUY◆	3.7M	$0.5349	$2M	—	Open the original filing on SEC.gov